600572 Zhejiang Conba Pharmaceutical
- 5.36
- +0.06+1.13%
Zhejiang Conba Pharmaceutical News
Announcement regarding participation in the 2023 Shanghai Stock Exchange main board health collective performance presentation.
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Announcement on attending the 2023 Shanghai Main Board Health Group Performance Briefing
Announcement on the implementation of the company's 2023 equity allocation
Legal Opinions
Announcement of Resolutions of the Company's 2023 Annual General Meeting of Shareholders
Legal Opinion of Beijing Guantao Zhongmao (Hangzhou) Law Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Kangenbei Pharmaceutical Co., Ltd.
2023 Annual General Meeting of Shareholders Meeting Materials
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Prompt Announcement on Convening the 2023 Annual General Meeting of Shareholders
Announcement on the repurchase ratio of 2% of the company's shares through centralized bidding
Conn Bay 2024 First Quarter Report
Special report of the board of directors on the self-inspection of the independence of independent directors
The company's 2023 internal control evaluation report
Independent Director's Debriefing Report
Accounting firm's special explanation on the capital occupied by the company's controlling shareholders and other related parties
Conn Bay 2023 Environmental, Social and Corporate Governance (ESG) Report
Report on the performance of the Audit Committee of the Board of Directors in 2023
Independent Directors' Self-Audit Report on Independence in 2023
Internal control audit report
Analysis
Price Target
No Data
